Alembic Pharmaceuticals Limited et al v. GlaxoSmithKline LLC et al
| Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. |
| Glaxo Group Limited and GlaxoSmithKline LLC |
| 1:2018cv01513 |
| September 28, 2018 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 26, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 PROPOSED Consent Judgment, by GlaxoSmithKline LLC. (Farnan, Brian) Modified on 11/26/2018 (nms). |
SO ORDERED, re #6 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to 11/26/2018 (*Reset Answer Deadlines: GlaxoSmithKline LLC answer due 11/26/2018). Signed by Judge Richard G. Andrews on 11/16/2018. (nms)
|
| Filing 6 STIPULATION TO EXTEND TIME for Defendant GlaxoSmithKline LLC to answer, move or otherwise respond to the Complaint to 11/26/2018 - filed by GlaxoSmithKline LLC. (Farnan, Brian) |
|
SO ORDERED, re #5 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to 11/16/2018 (*Reset Answer Deadlines: GlaxoSmithKline LLC answer due 11/16/2018). Signed by Judge Richard G. Andrews on 11/9/2018. (nms)
|
| Filing 5 STIPULATION TO EXTEND TIME for Defendant GlaxoSmithKline LLC to answer, move or otherwise respond to the Complaint to 11/16/2018 - filed by GlaxoSmithKline LLC. (Farnan, Brian) |
| Summons Issued with Magistrate Consent Notice attached as to GlaxoSmithKline LLC on 10/18/2018. (ceg) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| No Summons Issued. (crb) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alembic Pharmaceuticals, Ltd., Corporate Parent Alembic Global Holdings S/A for Alembic Pharmaceuticals, Inc. filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (crb) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,637,512 ;9,144,547. (crb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Glaxo Group Limited, GlaxoSmithKline LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2470666.) - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (Attachments: #1 Exhibit A and B, #2 Civil Cover Sheet)(crb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
